SAN DIEGO, Jan. 18, 2018 -- National substance abuse and mental health news provider announces new informational pages to be built for New Jersey cities. The Recover known for their numerous resource pages are completing city specific posts for New Jersey drug addiction help.
|
|||||
Finding drug addiction news in a particular city can be difficult, and for drug addicts and family members finding the right information is imperative. The Recover has a team of writers researching all the drug and alcohol statistics for each city in New Jersey and posting it for readers to review. The drug news source is also providing information about receiving help for addiction or mental health within the state.
The drug epidemic in New Jersey continues to hammer residents with overdoses and drug related crimes. The state of New Jersey ranks one of the highest among states suffering from substance abuse. Inpatient drug rehabs in New Jersey offer treatment for those fortunate enough to enter into a rehab. But, many suffer with little or no options due to lack of insurance or no insurance with no ability to pay.
The new pages for New Jersey will outline options for those who have insurance as well as resources for those looking for state funded facilities. In addition, information about clean needle locations are listed if available, to reduce the increased risk of contracting and spreading fatal blood-borne diseases. New Jersey syringe exchange programs will be provided with phone number and location.
Family members searching for loved ones want to know how to find the best rehab centers in NJ, and how much they cost. The pages will provide the amenities of each center located in the city, as well as the cost associated with treatment. Often time’s insurance can cover most if not all of the treatment needed for recovery.
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Avenue #101a, Temecula, CA 92590
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fa3a7654-cbed-4ad2-b897-cac45ca88012


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



